201. Diagnosis and management of chronic ITP: comments from an ICIS expert group.
- Author
-
Grainger JD, Bolton-Maggs PH, Godeau B, Bussel J, Donato H, Elalfy M, Hainmann I, Matzdorff A, Müller-Beissenhirtz H, Rovó A, and Tichelli A
- Subjects
- Adult, Antigens, Human Platelet immunology, Autoimmunity, Bone Marrow immunology, Bone Marrow physiopathology, Child, Chronic Disease, Humans, Purpura, Thrombocytopenic, Idiopathic immunology, Purpura, Thrombocytopenic, Idiopathic physiopathology, Purpura, Thrombocytopenic, Idiopathic diagnosis, Purpura, Thrombocytopenic, Idiopathic therapy
- Abstract
Immune thrombocytopenia (ITP) is a common disorder in children and adults. In a patient with newly diagnosed ITP, the treatment strategy is relatively well defined. Second-line treatments are more controversial, and the management of chronic ITP is even more so. During the 3rd ICIS Expert Meeting on Consensus and Development of Strategies in ITP, held in Basel on September 3-5, 2009, a group of experts were tasked with reaching a consensus on some frequently asked questions relating to diagnosis and management of children and adults with chronic ITP. The content of this article is designed to provide a practical support to trained haematologists in their care of patients with chronic ITP.
- Published
- 2010
- Full Text
- View/download PDF